首页> 美国卫生研究院文献>The Journal of Biological Chemistry >Role of Bound Zn(II) in the CadC Cd(II)/Pb(II)/Zn(II)-responsive Repressor
【2h】

Role of Bound Zn(II) in the CadC Cd(II)/Pb(II)/Zn(II)-responsive Repressor

机译:结合的Zn(II)在CadC Cd(II)/ Pb(II)/ Zn(II)响应中的作用 阻遏物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The Staphylococcus aureus plasmid pI258 cadCA operon encodes a P-type ATPase, CadA, that confers resistance to Cd(II)/Pb(II)/Zn(II). Expression is regulated by CadC, a homodimeric repressor that dissociates from the cad operator/promoter upon binding of Cd(II), Pb(II), or Zn(II). CadC is a member of the ArsR/SmtB family of metalloregulatory proteins. The crystal structure of CadC shows two types of metal binding sites, termed Site 1 and Site 2, and the homodimer has two of each. Site 1 is the physiological inducer binding site. The two Site 2 metal binding sites are formed at the dimerization interface. Site 2 is not regulatory in CadC but is regulatory in the homologue SmtB. Here the role of each site was investigated by mutagenesis. Both sites bind either Cd(II) or Zn(II). However, Site 1 has higher affinity for Cd(II) over Zn(II), and Site 2 prefers Zn(II) over Cd(II). Site 2 is not required for either derepression or dimerization. The crystal structure of the wild type with bound Zn(II) and of a mutant lacking Site 2 was compared with the SmtB structure with and without bound Zn(II). We propose that an arginine residue allows for Zn(II) regulation in SmtB and, conversely, a glycine results in a lack of regulation by Zn(II) in CadC. We propose that a glycine residue was ancestral whether the repressor binds Zn(II) at a Site 2 like CadC or has no Site 2 like the paralogous ArsR and implies that acquisition of regulatory ability in SmtB was a more recent evolutionary event.
机译:金黄色葡萄球菌质粒pI258 cadCA操纵子编码P型ATPase CadA,赋予对Cd(II)/ Pb(II)/ Zn(II)的抗性。表达受CadC调控,CadC是一种同二聚体阻遏物,在Cd(II),Pb(II)或Zn(II)结合后从cad操纵子/启动子解离。 CadC是金属调节蛋白ArsR / SmtB家族的成员。 CadC的晶体结构显示了两种类型的金属结合位点,分别称为位点1和位点2,同型二聚体各有两个。位点1是生理诱导物结合位点。两个位点2的金属结合位点在二聚化界面处形成。站点2在CadC中不受监管,但在同源SmtB中受监管。在这里,通过诱变研究了每个位点的作用。两个位点都结合Cd(II)或Zn(II)。但是,站点1对Cd(II)的亲和力高于Zn(II),站点2更喜欢Zn(II)而不是Cd(II)。解压或二聚化不需要位点2。将具有结合的Zn(II)的野生型和缺少位点2的突变体的晶体结构与具有和不具有结合的Zn(II)的SmtB结构进行比较。我们建议精氨酸残基允许SmtB中的Zn(II)调节,相反,甘氨酸导致缺乏Zn(II)的调节 在CadC中。我们建议甘氨酸残基是祖先是否阻遏物 在CadC等位点2上结合Zn(II)或在旁源ArsR中不结合位点2 并暗示在SmtB中获得监管能力是最近的事 进化事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号